• ONCE DAILY
  • NOT A STEROID
  • EASY TO APPLY

Over 1 Million Prescriptions and Counting...*

#1 Prescribed Branded Topical Across Eczema (Atopic Dermatitis), Seborrheic Dermatitis, and Plaque Psoriasis Combined†

Actor portrayal.

NOW AVAILABLE for ages 2–5

CREAM FOR:

MILD TO MODERATE ECZEMA (Atopic Dermatitis)

0.05% for ages 2–5 | 0.15% for ages 6+

 

FOAM FOR:

SEBORRHEIC DERMATITIS

FOAM 0.3% ages 9+

 

FOAM NOW AVAILABLE

CREAM & FOAM FOR:

PLAQUE PSORIASIS

CREAM 0.3% ages 6+ | FOAM 0.3% ages 12+

 

ZORYVE cream 0.15% is strongly recommended as a treatment option for adults with mild to moderate eczema (atopic dermatitis) by the American Academy of Dermatology 2025 guidelines.

Glamour Beauty & Wellness Awards 2024

Award-winning Eczema Treatment ZORYVE cream 0.15% for for mild to moderate eczema (atopic dermatitis) ages 6+

2025 Allure Best of Beauty Award Winner

Allure award-winner: ZORYVE cream 0.15% and 0.3%
ZORYVE foam 0.3%

National Psoriasis Foundation Recognized

First topical prescription medication recognized by the National Psoriasis Foundation‡ ZORYVE cream 0.3% and foam 0.3%

*Source: Data on file; August 2022–September 2025. Based on total amount of ZORYVE prescriptions for mild to moderate eczema (atopic dermatitis), plaque psoriasis, and seborrheic dermatitis combined. Excludes ZORYVE cream 0.05% for mild to moderate eczema (atopic dermatitis).
†Source: Data on file; June 2024–May 2025. Based on combined 4-week averages of total ZORYVE prescriptions. Excludes ZORYVE foam 0.3% for plaque psoriasis and ZORYVE cream 0.05% for mild to moderate eczema (atopic dermatitis).
‡For more information about the National Psoriasis Foundation Seal of Recognition, please go to psoriasis.org/seal-of-recognition-program/

ZORYVE Direct Savings Card

ZORYVE® (roflumilast) cream 0.3%|0.15%|0.05% and Topical Foam 0.3%

Eligible patients with commercial drug insurance may pay as little as $0 for ZORYVE§

GET SAVINGS CARD

§Subject to eligibility criteria and maximum program limitation. This offer is not valid for patients without commercial drug insurance or whose prescription claims are eligible to be reimbursed, in whole or in part, by any government program. Terms and Conditions may be viewed here.

ZORYVE® (roflumilast) cream 0.3%|0.15%|0.05% and Topical Foam 0.3%